Klinger; Ety

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klinger; Ety.The latest application filed is for "low frequency glatiramer acetate therapy".

Company Profile

1.16.33

Klinger; Ety - Tel Aviv IL
Klinger; Ety - Tzahala IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Low Frequency Glatiramer Acetate Therapy App 20190175494 - Klinger; Ety	2019-06-13
Low Frequency Glatiramer Acetate Therapy App 20190054013 - Klinger; Ety	2019-02-21
Low Frequency Glatiramer Acetate Therapy App 20180311149 - Klinger; Ety	2018-11-01
Low Frequency Glatiramer Acetate Therapy App 20180185274 - Klinger; Ety	2018-07-05
Low Frequency Glatiramer Acetate Therapy App 20180064639 - Klinger; Ety	2018-03-08
Low Frequency Glatiramer Acetate Therapy App 20170296464 - Klinger; Ety	2017-10-19
Low Frequency Glatiramer Acetate Therapy App 20170196803 - Klinger; Ety	2017-07-13
Low Frequency Glatiramer Acetate Therapy App 20170095523 - Klinger; Ety	2017-04-06
Low Frequency Glatiramer Acetate Therapy App 20160250251 - Klinger; Ety	2016-09-01
Low frequency glatiramer acetate therapy Grant 9,402,874 - Klinger August 2, 2	2016-08-02
Process For The Measurement Of The Potency Of Glatiramer Acetate App 20160025707 - Klinger; Ety	2016-01-28
Low frequency glatiramer acetate therapy Grant 9,155,776 - Klinger October 13, 2	2015-10-13
Low Frequency Glatiramer Acetate Therapy App 20150250845 - Klinger; Ety	2015-09-10
Low Frequency Glatiramer Acetate Therapy App 20150202247 - Klinger; Ety	2015-07-23
Low Frequency Glatiramer Acetate Therapy App 20150164977 - Klinger; Ety	2015-06-18
Process For The Measurement Of The Potency Of Glatiramer Acetate App 20150094488 - Klinger; Ety	2015-04-02
Low frequency glatiramer acetate therapy Grant 8,969,302 - Klinger March 3, 2	2015-03-03
Methods for treating multiple sclerosis using antisense oligonucleotides Grant 8,759,314 - Klinger , et al. June 24, 2	2014-06-24
Methods For Treating Multiple Sclerosis Using Antisense Oligonucleotides App 20130345293 - Klinger; Ety ; et al.	2013-12-26
Low Frequency Glatiramer Acetate Therapy App 20130165387 - Klinger; Ety	2013-06-27
Methods for treating multiple sclerosis using antisense oligonucleotides Grant 8,415,314 - Klinger , et al. April 9, 2	2013-04-09
Low frequency glatiramer acetate therapy Grant 8,399,413 - Klinger March 19, 2	2013-03-19
Process for the measurement of the potency of glatiramer acetate Grant 8,389,228 - Klinger March 5, 2	2013-03-05
Parenteral Formulations Of Peptides For The Treatment Of Systematic Lupus Erythematosus App 20130023485 - Cohen-Vered; Sharon ; et al.	2013-01-24
Process For The Measurement Of The Potency Of Glatiramer Acetate App 20120309671 - Klinger; Ety	2012-12-06
Low frequency glatiramer acetate therapy Grant 8,232,250 - Klinger July 31, 2	2012-07-31
Low Frequency Glatiramer Acetate Therapy App 20120071416 - Klinger; Ety	2012-03-22
Process For The Measurement Of The Potency Of Glatiramer Acetate App 20110189706 - Klinger; Ety	2011-08-04
Process for the measurement of the potency of glatiramer acetate Grant 7,923,215 - Klinger April 12, 2	2011-04-12
Low frequency glatiramer acetate therapy App 20110046065 - Klinger; Ety	2011-02-24
Methods for treating multiple sclerosis using antisense oligonucleotides App 20100119480 - Klinger; Ety ; et al.	2010-05-13
Parenteral formulations of peptides for the treatment of systemic lupus erythematosus App 20090169559 - Cohen-Vered; Sharon ; et al.	2009-07-02
Process for the measurement of the potency of glatiramer acetate App 20090053253 - Klinger; Ety	2009-02-26
Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus App 20080287366 - Cohen-Vered; Sharon ; et al.	2008-11-20
Process for the measurement of the potency of glatiramer acetate Grant 7,429,374 - Klinger September 30, 2	2008-09-30
Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus Grant 7,294,687 - Cohen-Vered , et al. November 13, 2	2007-11-13
Combination Therapy With Glatiramer Acetate and Riluzole App 20070244056 - Hayardeny; Liat ; et al.	2007-10-18
Parenteral formulations of peptides for the treatment of systemic lupus erythematosus App 20050008634 - Cohen-Vered, Sharon ; et al.	2005-01-13
Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus App 20040180059 - Cohen-Vered, Sharon ; et al.	2004-09-16
Process for the measurement of the potency of glatiramer acetate App 20030170729 - Klinger, Ety	2003-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.